Main Logo
Logo

Society for Pediatric Radiology – Poster Archive

  177
  0
  0
 
 


Final ID: Poster #: SCI-001

Myocardial Perfusion Abnormalities in MIS-C can be seen on Spectral Detector CT

Purpose or Case Report: As more pediatric patients are infected with severe acute respiratory syndrome coronavirus 2 during the coronavirus disease 2019 (COVID-19) pandemic, more have been diagnosed with multisystemic inflammatory syndrome in children (MIS-C). Early research investigations into MIS-C show cardiac involvement presenting as elevated troponins, ventricular dysfunction, electrical conduction abnormalities, and pericardial effusions. MIS-C may result in myocardial perfusion defects visualized with nuclear medicine imaging and magnetic resonance imaging (MRI), however these perfusion defects on contrast enhanced computed tomography (CT) have not yet been described.
Methods & Materials: An institutional radiology electronic database search for “MIS-C”, “MISC”, “COVID”, and “COVID-19” in either the report or requested indication was performed. Exams were included if intravenous contrast was given and in the descending aorta, the entirety of the heart was seen, and if performed on a spectral detector CT scanner. A review was performed to confirm the diagnosis of coronavirus infection prior to the CT and clinical diagnosis of MIS-C.
Iodine maps of the myocardium and presence or absence of regional perfusion abnormality was recorded. Circular regions of interest (ROI) were drawn in the left ventricular myocardium at the area of visually decreased and visually normal perfusion. The Hounsfield units (HU) and iodine map (mg/mL) values were recorded for each ROI.
Results: The initial search found 40 exams in 37 patients with six exams on six different patients meeting inclusion criteria. All six patients demonstrated perfusion defects on visual inspection of static iodine map images. Because of differences in exact contrast bolus timing, no definite quantitative threshold could be determined.
Chart review and review of imaging showed other findings of MIS-C and COVID-19 pneumonia. All patients had reported chest pain at rest and worsening with exertion. Four had elevated troponin levels while toponin levels were not available for the other two.
Conclusions: Myocardial perfusion defects can be visualized on contrast enhanced SDCT in patients with MIS-C from COVID-19. Creating iodine maps of the myocardium increases confidence that differences in attenuation are truly from myocardial perfusion abnormalities. When obtaining contrast enhanced CT in children with COVID-19, performing the exam on a SDCT scanner with appropriate contrast timing can visualize MIS-C related myocardial perfusion abnormalities.
  • Simmons, Curtis  ( Phoenix Children's Hospital , Phoenix , Arizona , United States )
  • Goncalves, Luis  ( Phoenix Children's Hospital , Phoenix , Arizona , United States )
  • Southard, Richard  ( Phoenix Children's Hospital , Phoenix , Arizona , United States )
  • Bardo, Dianna  ( Ann and Robert H Lurie Children's Hospital of Chicago , Chicago , Illinois , United States )
Session Info:

Posters - Scientific

Cardiovascular

SPR Posters - Scientific

More abstracts on this topic:
Cardiac Implantable Devices are NOT a Contraindication to MRI: Time for a Paradigm Shift

De Leon-benedetti Laura, Ramirez Suarez Karen, Otero Hansel, Rapp Jordan, Biko David, Smith Christopher, Serai Suraj, White Ammie

Spectrum of imaging findings in Interruption of the Aortic Arch; what the Radiologist needs to know.

Rebolledo Signe, Greenberg S Bruce, Lyons Karen

Preview
Poster____SCI-001.pdf
You have to be authorized to contact abstract author. Please, Login or Signup.

Please note that this is a separate login, not connected with your credentials used for the SPR main website.

Not Available

Comments

We encourage you to join the discussion by posting your comments and questions below.

Presenters will be notified of your post so that they can respond as appropriate.

This discussion platform is provided to foster engagement, and stimulate conversation and knowledge sharing.

Please click here to review the full terms and conditions for engaging in the discussion, including refraining from product promotion and non-constructive feedback.

 

You have to be authorized to post a comment. Please, Login or Signup.

Please note that this is a separate login, not connected with your credentials used for the SPR main website.


   Rate this abstract  (Maximum characters: 500)